SYNC (SYNC) News
Track canonical SquawkNews coverage tagged to SYNC, SYNC. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
Sycona shares rise on positive gene therapy trial results
Beacon Therapeutics, a Syncona portfolio company, is developing laru-zova for XLRP (inherited retinal disease). The stock jumped after positive drug trial results were reported.
EQUITY | Sep 21, 2026, 08:00 AM UTC
M
Syncona Says Beacon Therapeutics Reports Positive Topline in Vista Trial
Syncona said Beacon Therapeutics delivered a positive topline result in its Phase II/III Vista trial.
EQUITY | Sep 21, 2026, 06:28 AM UTC